FDA approves RSV monoclonal antibody for youngest kids; a 9-year-old's experience at a weight-management clinic

The drug is a a potential game-changer for a disease that is the No. 1 cause of hospitalization of babies in this country.

July 17, 2023 Check out STAT+

Sponsored By

Brittany Bravo for STAT For a 9-year-old patient at a Los Angeles obesity clinic, barriers to health are everywhere At UCLA's sought-after Fit Clinic, overstretched doctors and determined families seek behavioral treatments for obesity in children. By Isabella Cueto FDA approves RSV monoclonal antibody for infants, young children at high risk Use of the antibody treatment, the brand name for which is Beyfortus, still needs to be recommended by the ACIP. By Helen Branswell STAT+ | Detailed data confirm benefits — and risks — of Eli Lilly's Alzheimer's drug The data, while positive, leave physicians with lingering questions about the Alzheimer's drug's impact on patients. By Adam Feuerstein Molly Ferguson for STAT How telehealth startups are trying to fill the menopause care vacuum More than a dozen telehealth companies have started up to serve women in and approaching menopause, including with hormone therapy.  By Katie Palmer STAT+ | As fear rises over AI, Google and Epic fight stronger regulation of the technology in health care Google, Amazon, Epic, health insurers, and large health care providers are fighting AI regulation proposed by ONC. By Casey Ross Opinion: No one — M.D. or otherwise — should use the honorific 'doctor' with patients States are legislating who gets to use the honorific "doctor." But that's the completely wrong approach here. By Stephanie W. Edmonds and Alden A. Bush and Ginny L. Ryan Listen: Wildfire pollution widens asthma inequities on Long Island Wyandanch has some of the highest rates of asthma and the highest rate of pediatric asthma ER visits on Long Island. By Nicholas StFleur STAT+ | Blue Cross Blue Shield plans in California evaded $170 million in taxes, whistleblower says A former employee of Blue Shield of California says it evaded $111 million in taxes, and that Anthem Blue Cross evaded $60 million. By Bob Herman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser